Validation of Aseptic Process in Sterile Pharmaceutical Facility in accordance with ICH Guideline
Abstract
This review article focuses on the validation procedures and guidelines outlined by the International Council for Harmonization (ICH) for ensuring the efficacy and safety of aseptic processes in sterile pharmaceutical facilities. Aseptic processing is critical in pharmaceutical manufacturing to prevent contamination and ensure product sterility. The ICH guidelines provide a comprehensive framework for the validation of aseptic processes, encompassing facility design, equipment qualification, process validation, and ongoing monitoring. Aseptic validation is a systematic process that ensures sterile products are consistently manufactured under controlled conditions.
It begins with facility and equipment design, focusing on cleanroom layout, air handling systems (HVAC), and controlled environments that minimize contamination risk. Personnel qualification and training are critical to maintaining aseptic practices. The validation process typically includes: Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ), Media Fill / Process Simulation. Various techniques such as environmental monitoring, media fill studies, and microbiological testing are employed to assess the ongoing performance of aseptic processes. Adherence to ICH guidelines not only ensures regulatory compliance but also promotes the production of high-quality, safe, and efficacious sterile pharmaceutical products. This review consolidates key principles and best practices for validating aseptic processes, serving as a valuable resource for pharmaceutical professionals involved in sterile manufacturing and regulatory compliance.
Downloads
References
2. Choudhary N, Patil B, Choukse R, Varma AK, Bairagee D, et al. Validation of Sterile Water for Injection in Pharmaceutical Industry and Othersterile Facility: Asian Journal of Pharmaceutical Research and Development. 2019 Feb 15 [cited 2023 Sept 09]; 7(1):50-61. Available from: https://www.ajprd.com/index.php/journal/article/view/444
3. Sharma S, Singh Gurpreet. Process validation in pharmaceutical industry: an overview. JDDT. 2013 [cited 2023 Nov 14] ;3(4):184-8. Available from: https://pdfs.semanticscholar.org/64ab/ffa95410b837216418142d03d9cf60d8948d.pdf
4. Kastango ES. Quality-control analytical methods: USP chapter <797> compounded sterile preparations sterility requirements and their relationship to beyond-use dating. International Journal of Pharmaceutical Compounding. 2004 Sep 1, [cited 2024 Jan 02]; 8(5):393. Available from: https://www.proquest.com/openview/0c9678f0569e41ef227978596a35a2d3/1?pq-origsite=gscholar&cbl=32986
5. Talekar AR, Pise AG. Systematic Approach of Autoclave Qualification: A Review. Int J Med Phar Sci Vol. 2023 Sep [cited 2024 Feb 02]; 13(9):1. Available from: https://ijmps.org/uploads/233_pdf.pdf
6. 3M TM Attest TM Steam Chemical Integrator, St. Paul (MN) 3M Company [2024 February 02]; Available from: https://multimedia.3m.com/mws/media/356429O/3mattest-steam-ci-techinfo-70200907106us-pdf.pdf
7. Bryan D, Marback RC. Laminar-airflow equipment certification: what the pharmacist needs to know: American Journal of Hospital Pharmacy. 1984 Jul 1 [cited 03 May 2024]; 41(7):1343-9. Available from: https://academic.oup.com/ajhp/article-abstract/41/7/1343/5196654
8. Patil AB, Karnalli AP. Validation and Various Qualifications in HVAC System-A Review from Pharmaceutical Quality Assurance Prospect. International Journal of Pharmaceutical Quality Assurance. 2018 [cited 07 May 2024]; 9(03):281-6. Available from: https://impactfactor.org/PDF/IJPQA/9/IJPQA,Vol9,Issue3,Article11.pdf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM





